XORTX Therapeutics (XRTX) Return on Assets (2021 - 2026)

XORTX Therapeutics' Return on Assets history runs 6 years deep, the most recent figure standing at 0.03% for Q1 2026.

• Quarterly Return on Assets fell 2.0% year-over-year to 0.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03% (down 2.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Assets was 0.03% for Q1 2026 at XORTX Therapeutics, down from 0.03% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q1 2022 and bottomed at 0.03% in Q1 2026.
• A 5-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Assets.
• Annual changes were most pronounced in 2022 — Return on Assets changed 0 bps — and 2025, when it slipped 2 bps.
• XORTX Therapeutics' Return on Assets stood at 0.01% in 2022, then plunged by 45 bps to 0.01% in 2023, then fell by 8 bps to 0.01% in 2024, then tumbled by 240 bps to 0.03% in 2025, then retreated by 12 bps to 0.03% in 2026.
• Business Quant data shows XRTX's Return on Assets at 0.03% in Q1 2026, 0.03% in Q4 2025, and 0.01% in Q3 2025.